Invention Grant
- Patent Title: Azaindazoles
-
Application No.: US14344110Application Date: 2012-09-12
-
Publication No.: US09073924B2Publication Date: 2015-07-07
- Inventor: Joelle Lorraine Burgess , Neil W. Johnson , Steven David Knight , Louis Vincent LaFrance, III , William Henry Miller , Kenneth Allen Newlander , Stuart Paul Romeril , Meagan B. Rouse , Dominic Suarez , Xinrong Tian , Sharad Kumar Verma
- Applicant: Joelle Lorraine Burgess , Neil W. Johnson , Steven David Knight , Louis Vincent LaFrance, III , William Henry Miller , Kenneth Allen Newlander , Stuart Paul Romeril , Meagan B. Rouse , Dominic Suarez , Xinrong Tian , Sharad Kumar Verma
- Applicant Address: US DE Wilmington, New Castle
- Assignee: GlaxoSmithKline LLC
- Current Assignee: GlaxoSmithKline LLC
- Current Assignee Address: US DE Wilmington, New Castle
- Agent Duke M. Fitch; John Lemanowicz; William R. Majarian
- International Application: PCT/US2012/054785 WO 20120912
- International Announcement: WO2013/039988 WO 20130321
- Main IPC: C07D471/02
- IPC: C07D471/02 ; C07D471/04
Abstract:
Herein are disclosed azaindazoles of formula (I) where the various groups are defined herein, and which are useful for treating cancer.
Public/Granted literature
- US20140343056A1 AZAINDAZOLES Public/Granted day:2014-11-20
Information query
